Tolerance to the foetal 'allograft' has been extensively studied in the pas
t few years, providing interesting new insights. In addition to a potential
role for HLA-G, which has been widely discussed, there are hypotheses sugg
esting roles for several other molecules or cells: leukemia inhibitory fact
or and its receptor; indoleamine 2.3-dioxygenase; the Th1/Th2 balance; supp
ressor macrophages; hormones such as progesterone or the placental growth h
ormone; CD95 and its ligand; and, as recently proposed, annexin II. Toleran
ce of the foetal allograft is probably the consequence of a wide panel of m
echanisms that may or may not be pregnancy-specific, that are of major or s
econdary importance and that may be interconnected.